In one paragraphArticle in Genes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
19 authors.
Gaber BergantClinical Institute for Genomic Medicine, University Medical Center Ljubljana, 1000 Ljubljana, Slovenia.ORCID 0000-0003-4498-1042 Vesna M van MiddenDepartment of Neurology, University Medical Center Ljubljana, 1000 Ljubljana, Slovenia.ORCID 0000-0003-4653-8503 Polina TsygankovaClinical Institute for Genomic Medicine, University Medical Center Ljubljana, 1000 Ljubljana, Slovenia.ORCID 0000-0003-3998-3609 Dorian LasloClinical Institute for Genomic Medicine, University Medical Center Ljubljana, 1000 Ljubljana, Slovenia.
Valentino RačkiDepartment of Neurology, Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia.
Dejan GeorgievDepartment of Neurology, University Medical Center Ljubljana, 1000 Ljubljana, Slovenia.ORCID 0000-0003-1832-3441 Eliša PapićDepartment of Neurology, Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia.ORCID 0000-0003-4405-5460 Marija BrankovićDepartment for Clinical Genetics, University Children's Hospital, 11000 Belgrade, Serbia.ORCID 0000-0001-5208-147X Marina SvetelNeurology Clinic, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Nataša TeranClinical Institute for Genomic Medicine, University Medical Center Ljubljana, 1000 Ljubljana, Slovenia.
Natasa Dragasević MiskovićNeurology Clinic, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Aleš MaverClinical Institute for Genomic Medicine, University Medical Center Ljubljana, 1000 Ljubljana, Slovenia.
Ivana NovakovićInstitute of Human Genetics, Neurology Clinic, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Zvezdan PirtošekDepartment of Neurology, University Medical Center Ljubljana, 1000 Ljubljana, Slovenia.ORCID 0000-0002-5495-944X Vladimira VuletićDepartment of Neurology, Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia.
Borut PeterlinClinical Institute for Genomic Medicine, University Medical Center Ljubljana, 1000 Ljubljana, Slovenia.ORCID 0000-0001-7824-4978 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
MitochondriaParkinson DiseaseAge of OnsetCell NucleusDNA, MitochondrialExome SequencingFemaleGenetic Predisposition to DiseaseGenetic VariationGerm-Line MutationHumansMaleMiddle AgedRetrospective StudiesDNA, Mitochondrialmitochondrial metabolismmitochondrial variantsmutation burden analysisParkinson’s disease
Identifiers
PMID42074590
PMCPMC13116834
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390